Literature DB >> 32321612

Prevention of nosocomial COVID-19: Another challenge of the pandemic.

Jens T Van Praet1,2, Bram Claeys3, Ann-Sofie Coene4, Katelijne Floré5, Marijke Reynders5.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32321612      PMCID: PMC7198455          DOI: 10.1017/ice.2020.166

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


× No keyword cloud information.
To the Editor—Coronavirus disease 2019 (COVID-19) is an illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recently emerged novel virus that is currently spreading globally.[1] Its clinical presentation varies from mild, sometimes unrecognized, respiratory symptoms to overwhelming pneumonia and multiple-organ failure leading to death. The virus is probably mainly transmitted via respiratory droplets and can survive on surfaces for several days. The incubation period varies between 4 and 14 days, and patients can be contagious before the onset of symptoms.[2] The duration of infectivity is uncertain, with one study reporting that 90% of mild cases had a negative real-time polymerase chain reaction (PCR) test by day 10.[3] On March 13, 2020, the first outpatient with COVID-19 was admitted to our hospital, a 1,182-bed acute- and tertiary-care hospital in Belgium consisting of 3 separate campuses. In week 13 (March 16–22), we observed that 4 patients who had been hospitalized for other reasons presented with COVID-19 (Table 1). COVID-19 was diagnosed based on a positive real-time PCR test from a nasopharyngeal swab and/or the presence of typical radiographic abnormalities on a computed tomography (CT) scan of the lungs. Because the hospitalization duration of these patients clearly exceeded the minimal incubation period, these infections were considered nosocomially acquired, transmitted by healthcare workers or external visitors. We implemented several measures to prevent further cases of nosocomial transmission. First, from the beginning of week 12, we screened all healthcare personnel with direct patient contact for cases of low-grade fever (>37.4°C) and acute developing or worsening respiratory symptoms and tested possible cases using nasopharyngeal swabs and real-time PCR. Positive screening resulted in removal from the work floor for 14 days.
Table 1.

Characteristics of the Nosocomial COVID-19 Cases in Week 13

Patient Sex and AgeDays of Hospitalization Before Onset SymptomsOriginal Reason for AdmissionClinical Symptoms of COVID-19Outcome
Female, 78 y40Humerus fractureFever (>38.5°C) and coughFull recovery
Male, 75 y25Acute kidney injury and nephrolithiasisFever (> 38.5°C)Full recovery
Female, 90 y32LumbalgiaFever (>38.5°C) and coughFull recovery
Male, 65 y8Cholangitis with underlying liver metastasesLow-grade fever (>38.2°C) and respiratory failureDeceased
Characteristics of the Nosocomial COVID-19 Cases in Week 13 Furthermore, we cancelled all elective consultations and procedures, and we prohibited visits to the hospital with restrictive exceptions for intensive care, pediatric wards, and obstetric wards, as required by government regulations from March 13 (end of week 12). From this day forward, all healthcare workers were obligated to wear surgical masks as personal protective equipment during patient contact, regardless of their own symptoms. Additionally, we created physically separated wards for patients with or without COVID-19. The number of admissions of outpatients with COVID-19 increased from 5 in week 12 to 22 in week 13, 49 in week 14 and 42 in week 15, illustrating the increasing incidence of COVID-19 during the beginning of the epidemic in Belgium. In these same weeks, the screening positivity rates of symptomatic healthcare workers in our hospital were 8.6% (6 out of 70), 31% (17 out of 54), 39% (16 out of 41) and 28% (16 out of 57), respectively and the numbers of patients diagnosed with probable nosocomial COVID-19 were 0, 4, 4, and 23, respectively. We defined probable nosocomial COVID-19 as a diagnosis made beyond 4 days of hospitalization and the absence of clinical suspicion of COVID-19 upon admission. Of 31 probable nosocomial COVID-19 infections, 22 (71%) were observed at geriatric wards. Our data indicate that nosocomially acquired COVID-19 can be observed at the start of a local epidemic and represents another challenge of the pandemic. Despite diverse and strictly followed preventive measures, we observed increasing numbers of new cases in our hospital during the first weeks of the epidemic, especially in geriatric wards. Further studies are required to identify the optimal preventive approach, which will probably include the regular screening of all asymptomatic healthcare personnel working at wards with high rates of nosocomial transmission.
  7 in total

1.  The Impact of Real-Time Whole-Genome Sequencing in Controlling Healthcare-Associated SARS-CoV-2 Outbreaks.

Authors:  Rodric V Francis; Harriet Billam; Mitch Clarke; Carl Yates; Theocharis Tsoleridis; Louise Berry; Nikunj Mahida; William L Irving; Christopher Moore; Nadine Holmes; Jonathan K Ball; Matthew Loose; C Patrick McClure
Journal:  J Infect Dis       Date:  2022-01-05       Impact factor: 7.759

2.  Trends in US Kidney Transplantation During the COVID-19 Pandemic.

Authors:  Stephen J Bordes; Lisandro Montorfano; Wesley West-Ortiz; Roberto Valera; Alejandro Cracco; Mileydis Alonso; Antonio D Pinna; Samer Ebaid
Journal:  Cureus       Date:  2020-12-14

3.  COVID-19 seroprevalence among hospital staff and preprocedural patients in Thai community hospitals: a cross-sectional study.

Authors:  Tanawin Nopsopon; Krit Pongpirul; Korn Chotirosniramit; Narin Hiransuthikul
Journal:  BMJ Open       Date:  2021-10-29       Impact factor: 3.006

4.  Incidence, Characteristics, and Outcome of COVID-19 in Adults on Kidney Replacement Therapy: A Regionwide Registry Study.

Authors:  Johan De Meester; Dirk De Bacquer; Maarten Naesens; Bjorn Meijers; Marie M Couttenye; An S De Vriese
Journal:  J Am Soc Nephrol       Date:  2020-11-05       Impact factor: 10.121

5.  Hip Fractures in the Elderly During the COVID-19 Pandemic: A Latin-American Perspective With a Minimum 90-Day Follow-Up.

Authors:  Tomas Zamora; Felipe Sandoval; Hugo Demandes; Javier Serrano; Javiera Gonzalez; Maria Jesus Lira; Ianiv Klaber; Maximiliano Carmona; Eduardo Botello; Daniel Schweitzer
Journal:  Geriatr Orthop Surg Rehabil       Date:  2021-07-09

6.  Impact of a Nosocomial COVID-19 Outbreak on a Non-COVID-19 Nephrology Ward during the First Wave of the Pandemic in Spain.

Authors:  María Milagro Montero; Carlota Hidalgo López; Inmaculada López Montesinos; Luisa Sorli; Cristina Barrufet Gonzalez; Judith Villar-García; Roberto Güerri-Fernández; Milagros Herranz; Marta Crespo; María Dolores Arenas Jiménez; Julio Pascual; Cristina González Juanes; Juan P Horcajada
Journal:  Antibiotics (Basel)       Date:  2021-05-22

7.  Does nosocomial SARS-CoV-2 infection result in increased 30-day mortality? A multi-centre observational study to identify risk factors for worse outcomes in COVID-19 disease.

Authors:  Khurram Shahzad Khan; Hamish Reed-Embleton; Jen Lewis; James Saldanha; Sajid Mahmud
Journal:  J Hosp Infect       Date:  2020-09-17       Impact factor: 3.926

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.